PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HCV PATIENTS THAT ARE NON-RESPONDERS TO INTERFERON

摘要

The present invention provides compositions and methods of treatment of HCV infected subjects that are not sensitive to interferon treatment. Further, compositions and methods are provided for prevention of organ transplant rejection. The compositions of the invention comprise an anti microRNA-122 oligonucleotide, and are made for administration to a primate.